Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study)

International Retina Biosimilar Study Group (Inter BIOS Group)

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry